Brimonidine Formulations for Presbyopia

63/108,720 | U.S. Patent Application

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Location ELECTRONIC
Filed Nov. 2, 2020
Case Type Provisional
Status Provisional Application Expired
Child PCT/US21/57720 Published
Child 18/250,921 Pending
Last Updated: 1 year, 6 months ago
Date # Transaction
11/7/2021EXPIRED PROVISIONAL
10/5/2021Communication - Re: Power of Attorney (PTOL-308)N570 PUBLIC PROSECUTION
10/5/2021Communication - Re: Power of Attorney (PTOL-308)N570 PUBLIC PROSECUTION
10/5/2021Email Notification
10/5/2021Change in Power of Attorney (May Include Associate POA)
10/4/2021Correspondence Address Change
9/30/2021Electronic Filing System(EFS) Acknowledgment ReceiptN417 PUBLIC PROSECUTION
9/30/2021Power of AttorneyPA.. PUBLIC PROSECUTION
11/25/2020Filing ReceiptAPP.FILE.REC PUBLIC PROSECUTION
11/25/2020Email Notification
11/25/2020Application ready for PDX access by participating foreign offices
11/25/2020Application Is Now Complete
11/25/2020Filing Receipt
11/24/2020Application Dispatched from OIPE
11/24/2020Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
11/2/2020Application Data SheetADS PUBLIC PROSECUTION
11/2/2020Electronic Filing System(EFS) Acknowledgment ReceiptN417 PUBLIC PROSECUTION
11/2/2020Fee Worksheet (SB06)WFEE PUBLIC PROSECUTION
11/2/2020SpecificationSPEC PUBLIC PROSECUTION
11/2/2020PTO/SB/69-Authorize EPO Access to Search Results
11/2/2020Applicants have given acceptable permission for participating foreign
11/2/2020Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
11/2/2020Initial Exam Team nn